Charles Hiram Randall - Chief Strategy Officer at SAB Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Strategy Officer
Stock Symbol
SABS, SABSW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Charles Hiram Randall since 9/18/2023

Holdings reported by Charles Hiram Randall for SAB Biotherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Earnout Rights (Restricted Stock Units) 146K Oct 22, 2021 Direct Common Stock
Employee Stock Option (right to buy) 11.6K Oct 22, 2021 Direct Common Stock

Transactions reported by Charles Hiram Randall for SAB Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.